MA in Journalism from the University of Sunderland, NCTJ accreditation,
Editor of Cannabis Health (2019-2023); Contributor at Forbes (2023-present); Panel Moderator at Cannabis Europa, Product Earth, and Drug Science’s UK Patient Conference (2023); Reporter on women’s health, health technology, biotech, longevity, and neurorehabilitation medicine.
Forbes, Cannabis Health, Business of Cannabis, Drug Science.
Sarah is a highly respected journalist, with over a decade of experience in publishing and communications, the last four of which have been in specialist healthcare sectors. She is one of the few UK journalists specialising in cannabis-related health and policy, with work that spans the fields of science, medicine, wellness and drug policy. As the former editor of Cannabis Health, an industry-leading and award-winning title covering the potential of cannabis for health and wellbeing, she has been at the forefront of the UK medical cannabis sector for the last four years and has reported extensively, with a particular focus on patients and consumers. Under Sarah’s leadership, Cannabis Health won 'Best CBD Magazine' at the World CBD Awards 2022. She is now a regular contributor to Forbes, covering cannabis with a focus on Europe and has moderated panels at leading industry events, including Cannabis Europa, Product Earth and Drug Science’s UK Patient Conference, which she helped curate in November 2023. Beyond cannabis, Sarah also has experience reporting on women’s health, health technology, biotech, longevity and neurorehabilitation medicine. She has an NCTJ accreditation and graduated from her MA in Journalism at the University of Sunderland with a distinction. She has also completed specialist training through the Medical Cannabis Clinicians Society in the UK. Sarah is passionate about tackling stigma and misinformation with science, without losing sight of the importance of the patient experience. Through her journalism and content, she helps readers navigate complex topics in a way that resonates and aims to empower individuals to make informed decisions about their health and wellbeing, with accurate, evidence-based information.
Medical cannabis is not a cure for breast cancer, but growing evidence suggests it may help relieve treatment-related symptoms such as pain, nausea and anxiety. This guide explores current research, the role of clinical oversight, and how Releaf provides safe access to personalised cannabis-based care for breast cancer patients in the UK.
Despite medical cannabis being legal in the UK for almost six years, there is still confusion— and mixed messages—around the rights and responsibilities of patients when it comes to driving with their prescription.
To mark World Autism Acceptance Month this April, we’re exploring how cannabis-based treatments can be used to address some of the challenges autistic people face and help them better manage their daily lives.
Patients across the UK are facing significant challenges when it comes to healthcare, from long waiting lists, to an increasing prevalence of mental health issues and complex, chronic conditions. This blog aims to answer some common questions about accessing medical cannabis treatment in Northern Ireland and walk you through it step-by-step.
With rates of ADHD diagnosis on the rise in the UK, in honour of Neurodiversity Celebration Week, we’re celebrating Releaf patients who have opened up about their ADHD and how they found improved quality of life through medical cannabis.
Ahead of the Rugby Six Nations finals this month, we’re exploring how medical cannabis could aid recovery off the pitch and provide relief for athletes suffering from long-term injuries.
Accelerated by the pandemic, an increasing number of healthcare providers are now offering online services, whether through their booking systems or virtual appointments. But how do patients really feel about digital healthcare? We take a look.
Recovery from an eating disorder looks different for everyone. To mark the beginning of Eating Disorder Awareness Week (24 February-2 March 2025) this blog explores the potential role of medical cannabis, to support quality of life and wellbeing, as part of that journey.
A recent YouGov poll found greater support for prescription cannabis among MPs than the general public, challenging the common assumption that public opinion is more progressive than political sentiment. We take a closer look at the potential factors behind these figures.
Cancer affects the lives of millions of people around the world and everyone’s story is different. As a clinic offering personalised medical cannabis treatment, Releaf is embracing the theme for World Cancer Day on Tuesday 4 February and advocating for patients to be front and centre of their care.
Ahead of Parent Mental Health Day (Thursday 30 January) we’re breaking down the stigma around medical cannabis and parenting with the real-life stories of those who have found improved health and wellbeing for themselves and their families as a result.
Medical cannabis has been legal in the UK since 2018, but there is still a lot of confusion and misinformation out there around its regulation and the rights of medical cannabis patients.
The Food Standards Agency (FSA)— the body responsible for the regulation of consumer CBD products in the UK—has hinted at ambitious new targets for CBD products in the UK market, which could see a push for zero detectable THC levels.
Cannabis-based medicinal products (CBMPs) are now prescribed in a variety of forms in the UK. But one product type you won’t find in the formulary is cannabis resin.
While most people look for alternative treatment options because conventional medicines haven’t met their needs, an increase in prescription drug shortages in the UK is leaving more patients without access to effective medications.
If you’re new to medical cannabis treatment, it’s natural to have concerns about its safety, particularly regarding its potential psychoactive effects.
The winter months can be tough for all of us, but especially those living with chronic health conditions who may see their symptoms worsen with the lower temperatures.
More people throughout the UK are looking for alternative options to manage long-term health conditions.
Challenges like record-high waiting lists and the rising prevalence of chronic conditions are prompting interest in alternative treatment options, including medical cannabis.
Disability History Month, taking place from 14 November— 20 December highlights the history of the equality and human rights struggles of disabled individuals in the UK.
Millions of people in the UK are living with the effects of long covid. As many of the symptoms overlap with those of other conditions that can be managed with cannabis-based medicines, there is a growing interest in medical cannabis treatments for this population.
As new findings from an early health economic analysis suggest that prescribing medical cannabis on the NHS to treat chronic pain could save the state healthcare provider almost £4 billion every year, we take a closer look at the research.
We all experience stress occasionally— and sometimes it can even be useful. But if left unchecked it can become problematic, particularly for those living with long-term health conditions, the symptoms of which can be exacerbated by stress.
While awareness of medical cannabis has grown in recent years, there remains a huge knowledge gap when it comes to healthcare professionals and their understanding of this treatment.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient
